Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Barchart
Barchart
Neha Panjwani

Corteva's Q1 2025 Earnings: What to Expect

Indianapolis, Indiana-based Corteva, Inc. (CTVA) provides seed and crop protection solutions, which engages in the agriculture industry and food supply. Valued at $41.4 billion by market cap, the leading agricultural company offers seeds and crop protection products, as well as software solutions and digital services. The agricultural chemical and seed major is expected to announce its fiscal first-quarter earnings for 2025 after the market closes on Wednesday, May 7.

Ahead of the event, analysts expect CTVA to report a profit of $0.87 per share on a diluted basis, down 2.3% from $0.89 per share in the year-ago quarter. The company beat the consensus estimates in two of the last four quarters while missing the forecast on two other occasions. 

 

For the full year, analysts expect CTVA to report EPS of $2.98, up 16% from $2.57 in fiscal 2024. Its EPS is expected to rise 14.4% year over year to $3.41 in fiscal 2026. 

www.barchart.com

CTVA stock has outperformed the S&P 500’s ($SPX6% gains over the past 52 weeks, with shares up 10.7% during this period. Similarly, it outperformed the Materials Select Sector SPDR Fund’s (XLB7.7% dip over the same time frame.

www.barchart.com

On Feb. 5, CTVA shares closed down more than 2% after reporting its Q4 results. Its adjusted EPS of $0.32 did not meet Wall Street expectations of $0.34. The company’s revenue was $3.98 billion, beating Wall Street forecasts of $3.95 billion. CTVA expects full-year adjusted EPS in the range of $2.70 to $2.95, and expects revenue to be between $17.2 billion and $17.6 billion.

Analysts’ consensus opinion on CTVA stock is bullish, with a “Strong Buy” rating overall. Out of 21 analysts covering the stock, 14 advise a “Strong Buy” rating, two suggest a “Moderate Buy,” and five give a “Hold.” CTVA’s average analyst price target is $69.10, indicating a potential upside of 13.1% from the current levels.

On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.